Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)

NCT04706975 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Notalgia Paresthetica

Interventions

DRUG: difelikefalin 2.0 mg
DRUG: Placebo

Sponsor

Cara Therapeutics, Inc.